Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan
Masahiko Tomimatsu(Tokyo Women's Medical University), Masayuki Nakano(Nihon University), Makiko Taniai(Tokyo Women's Medical University), Hiroshi Obata(Tokyo Women's Medical University), Hiroaki Okuda(Tokyo Women's Medical University), Noriko Ishiguro(Tokyo Women's Medical University), Masakazu Yamamoto(Tokyo Women's Medical University), Ken Takasaki(Tokyo Women's Medical University), Akiko Saito(Tokyo Women's Medical University)
Cited by 110
Related Papers
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
|Cancer|1985|1.9k
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
|Radiology|2011|354
cHCC‐CCA
|Hepatology|2018|333